Radioimmunotherapy-punch
The logic of radioimmunotherapy(RIT) is in its SPECIFICITY and its "PUNCH".
In an earlier entry I wrote of RIT specificity as the antibodies in the medication attach to the lymphoma cells and kill them.
However, with treatment, there may be a few lymphoma cells that will not have antibodies attached to them. These lymphoma cells, then, remain alive and could potentially become troublesome. But, the RIT also has PUNCH,.
Punch means that the radioactive tag in the medication will kill cancer cells even when the medication is not physically attached to the lymphoma cell.
I was so pleased to have received Zevalin, a radioimmunotherapy agent. The added Punch effect signivicantly added to my feeling of confidence in my therapy.
Mort Diamond